Granted Patent
B2
US 10,294,233 · App. 16/136,314 · Granted May 21, 2019
Treatment of
Inventors:
Vern L. Schramm (New Rochelle, NY); Keith Clinch (Lower Hutt, NZ); Shivali Ashwin Gulab (Wellington, NZ)
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Methods of treating infections due to Helicobacter pylori ( H. pylori ), in particular in subjects having a peptic ulcer, are disclosed where the methods comprise administering inhibitors of H. pylori MTAN (5′-methylthioadenosine nucleosidase) to the subject.
Claims (4)
1. A compound having the structure
or a pharmaceutically acceptable salt thereof, or an ester thereof.
2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the structure
or a pharmaceutically acceptable salt thereof, or an ester thereof.
Assignments (1)
MERGER AND CHANGE OF NAME
Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Continuity (3)
Division
15118113
Provisional Application
61938755
· Feb 12, 2014